News Headlines Article

New research: low-dose aspirin regimen can cut risk of pancreatic cancer
Sacramento Bee

People on a long-term, low-dose aspirin regimen can cut their risk of pancreatic cancer nearly in half, according to a new study by researchers at Yale University. People who took 75 mg to 325 mg of aspirin per day for six years or less reduced their risk of developing pancreatic cancer by 39 percent, according to the study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.